143 related articles for article (PubMed ID: 36841156)
1. The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris.
Zhu Y; Su J; Zhang P; Deng M; Wu R; Liu Y; Su Y; Li S
Int Immunopharmacol; 2023 Apr; 117():109921. PubMed ID: 36841156
[TBL] [Abstract][Full Text] [Related]
2. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
[TBL] [Abstract][Full Text] [Related]
3. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
5. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
[TBL] [Abstract][Full Text] [Related]
6. Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris.
Pollmann R; Walter E; Schmidt T; Waschke J; Hertl M; Möbs C; Eming R
Front Immunol; 2019; 10():1375. PubMed ID: 31258541
[TBL] [Abstract][Full Text] [Related]
7. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
8. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
[TBL] [Abstract][Full Text] [Related]
10. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
[TBL] [Abstract][Full Text] [Related]
11. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
Front Immunol; 2018; 9():1935. PubMed ID: 30233569
[TBL] [Abstract][Full Text] [Related]
14. Targeting inducible costimulator expressed on CXCR5
Kim AR; Han D; Choi JY; Seok J; Kim SE; Seo SH; Takahashi H; Amagai M; Park SH; Kim SC; Shin EC; Kim JH
J Allergy Clin Immunol; 2020 Nov; 146(5):1070-1079.e8. PubMed ID: 32311391
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein compensation hypothesis fidelity assessment in Pemphigus.
Sielski L; Baker J; DePasquale MC; Attwood K; Seiffert-Sinha K; Sinha AA
Front Immunol; 2022; 13():969278. PubMed ID: 36211362
[TBL] [Abstract][Full Text] [Related]
16. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus.
Jerbi A; Hachicha H; Feki S; Abida O; Bahloul E; Sellami K; Bouzid A; Turki H; Masmoudi A; Masmoudi H
Tunis Med; 2021 Octobre; 99(10):992-999. PubMed ID: 35288901
[TBL] [Abstract][Full Text] [Related]
18. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
Front Immunol; 2018; 9():858. PubMed ID: 29922278
[No Abstract] [Full Text] [Related]
19. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
20. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
